Authors' Reply to Ganijee et al.: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults".
Saved in:
| Title: | Authors' Reply to Ganijee et al.: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults". |
|---|---|
| Authors: | Boettcher M; Clinical Pharmacology, Bayer AG, Research & Development, Building 0520, 42096, Wuppertal, Germany., Becker C; Clinical Pharmacology, Bayer AG, Research & Development, Building 0520, 42096, Wuppertal, Germany. corina.becker@bayer.com. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2023 Nov; Vol. 62 (11), pp. 1651-1653. Date of Electronic Publication: 2023 Sep 26. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37751065 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Authors' Reply to Ganijee et al.: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults". – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Boettcher+M%22">Boettcher M</searchLink>; Clinical Pharmacology, Bayer AG, Research & Development, Building 0520, 42096, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Becker+C%22">Becker C</searchLink>; Clinical Pharmacology, Bayer AG, Research & Development, Building 0520, 42096, Wuppertal, Germany. corina.becker@bayer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227606849%22">Clinical pharmacokinetics</searchLink> [Clin Pharmacokinet] 2023 Nov; Vol. 62 (11), pp. 1651-1653. <i>Date of Electronic Publication: </i>2023 Sep 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+part+of+Springer+Science%2BBusiness+Media%22">Adis, part of Springer Science+Business Media </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7606849 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1926 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203125963%22">03125963 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacokinet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37751065 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40262-023-01304-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1651 Titles: – TitleFull: Authors' Reply to Ganijee et al.: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults". Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boettcher M – PersonEntity: Name: NameFull: Becker C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2023 Nov Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1179-1926 Numbering: – Type: volume Value: 62 – Type: issue Value: 11 Titles: – TitleFull: Clinical pharmacokinetics Type: main |
| ResultId | 1 |
